Dow Jones Stocks To Buy And Watch In July: Microsoft Earnings Due

The Dow Jones Industrial Average rebounded just a little more than halfway through the month of July after ending June back near its recent lows. The best Dow Jones stocks to buy and watch in July are Apple (AAPL), Merck (MRK), Microsoft (MSFT) and UnitedHealth (UNH).

X

There are clear winners — and losers —halfway through the month of July. The top three performing Dow Jones stocks through July 18 were Merck, Chevron (CVX) and Amgen (AMGN) with advances of 20.5%, 18.9% and 8.4%, respectively.

The three biggest Dow Jones losers through July 18 were Disney (DIS), Nike (NKE) and Salesforce (CRM) with respective declines of 38.2%, 37.6% and 33.9% for the year.

The tech-heavy Nasdaq finished June down 29.5% for the year. The S&P 500 was down 20.6%, while the Dow Jones Industrial Average was down 15.3% through June 30.

What Is The Dow Jones Industrial Average?

Founded in 1896 with 12 stocks, the Dow Jones Industrial Average is one of the oldest stock market indexes. There are 30 Dow Jones stocks designed to serve as a bellwether for the general U.S. stock market. Other major stock indexes include the technology-heavy Nasdaq composite and the S&P 500 index — an index of the 500 largest companies in the United States.

Best Dow Jones Stocks To Watch

Source: IBD Data As Of July 18, 2022

Amid the current stock market rally — according to the IBD Big Picture — investors should focus on the top stocks that show strong relative strength. They could be some of the market’s leaders if the Dow Jones Industrial Average is able to extend its rebound.

Potential Dow Jones stocks to buy and watch in July that are in or near buy zones include Apple, Johnson & Johnson, Merck, Microsoft and UnitedHealth.

Stock Market ETF Strategy And How To Invest

Apple Stock

Apple stock dropped 0.55% Tuesday, threatening to extend a losing streak to three sessions. Apple shares are about 17% off their 52-week high, according to IBD MarketSmith chart analysis.

According to the IBD Stock Checkup, Apple stock shows an 83 out of a best-possible 99 IBD Composite Rating. The Composite Rating — an easy way to identify top growth stocks — is a blend of key fundamental and technical metrics to help investors gauge a stock’s strengths.

Merck Stock

Drug giant Merck broke out past a flat base’s 95.02 buy point in recent weeks, but is about 4% below the entry following Monday’s 0.5% rise. Merck shares moved up 1.2% Tuesday.

If the stock is able to regain the entry, the 5% buy area goes up to 99.77.

Microsoft Stock

Dow Jones software leader Microsoft sold of 3.3% Tuesday ahead of the company’s earnings results after the close. MSFT shares are about 27% off its 52-week high.

The company is expected to earn $2.29 a share on revenue of $52.3 billion.

UnitedHealth Stock

Health insurance giant and IBD Leaderboard stock UnitedHealth is in buy range above its double-bottom-with-handle base’s 518.80 buy point amid Tuesday’s 1.2% gain.

UNH stock shows a solid 95 out of a perfect 99 IBD Composite Rating, per the IBD Stock Checkup.

Tip: Before making any investment decisions, be sure to check current market conditions, and use IBD Stock Checkup to see if your stock gets passing ratings for the most important fundamental and technical criteria. To get ongoing chart analysis, and alerts to buy and sell signals, check out the unique features, stock lists and chart annotations at MarketSmith, Leaderboard and SwingTrader.

Be sure to follow Scott Lehtonen on Twitter at @IBD_SLehtonen for more on Dow Jones stocks and the stock market.

YOU MAY ALSO LIKE:

Top Growth Stocks To Buy And Watch

Learn How To Time The Market With IBD’s ETF Market Strategy

Find The Best Long-Term Investments With IBD Long-Term Leaders

Looking For The Next Big Stock Market Winners? Start With These 3 Steps

Join IBD Live And Learn Top Chart Reading And Trading Techniques From Pros